Discover Algeria | Press area | Contact  
English Français
Registration
English Français

September 26, 2024 | 3 months ago

  • More options

    Share on LinkedIn
    Share on Twitter

Pharmaceutical industry: the first 100% Made-in-Algeria insulin pen is born

A new era is dawning for the Algerian pharmaceutical industry with the imminent launch of a completely locally manufactured insulin. This product, developed by the Biocare Biotech Group, will be available in pen form for all age groups, from children to the elderly.

Algeria Invest
Legal Notices | Terms of Services
news-detail

This launch marks an important milestone in Algeria's efforts to achieve self-sufficiency in pharmaceutical production and improve the care of diabetic patients.

The Biocare Group is ensuring that this new production will be carried out entirely in Algeria, without recourse to imports, unlike previous practices where insulin was imported and then packaged in Algeria. This initiative is part of the government's efforts to strengthen the national pharmaceutical industry and ensure greater autonomy for medicines, particularly for the treatment of diabetes, a disease that affects a large part of the population.

The "Made in Algeria" insulin will be officially presented at a meeting in Algiers on Friday. This event will bring together health experts and doctors specialising in diabetes from the wilayas in the centre of the country. Representatives from the Ministries of Health and the Pharmaceutical Industry will also be present to provide health professionals with details and explanations about this product.

Algerian insulin pen: 2 different versions available

Marketing will begin in the coming days from Biocare's production facility in Oued Smar, Algiers, with gradual distribution through the country's pharmacies. The insulin will be available in two formulas: "Bio Rapid" for rapid glycaemic control and "Bio Mix", a mixture of rapid and slow insulin designed to stabilize blood glucose levels overnight.

Algeria has recently begun exporting its insulin pens to neighbouring countries such as Libya. The progress of the Algerian pharmaceutical industry does not stop there, as the national insulin production has influenced other more distant regions, such as Saudi Arabia, which recently received nearly 2.5 million insulin pens manufactured in Algeria.

September 29, 2024 | algeria-logo

  • More options

    Share on LinkedIn
    Share on Twitter
Subscribe to the economic newsletter